Posterior Reversible Encephalopathy Syndrome in Infection, Sepsis, and Shock

References

1. ↵
   Bartynski WS, Grabb BC, Zeigler Z, et al. Watershed imaging features and clinical vascular injury in cyclosporin A neurotoxicity. J Comput Assist Tomogr 1997;21:872–80

   CrossRefPubMed
2. ↵
   Bartynski WS, Zeigler Z, Spearman MP, et al. Etiology of cortical and white matter lesions in cyclosporin-A and FK-506 neurotoxicity. AJNR Am J Neuroradiol 2001;22:1901–14

   Abstract/FREE Full Text
3. ↵
   Schwartz RB, Bravo SM, Klufas RA, et al. Cyclosporine neurotoxicity and its relationship to hypertensive encephalopathy: CT and MR findings in 16 cases. AJR Am J Roentgenol 1995;165:627–31

   CrossRefPubMedWeb of Science
4. ↵
   Sanders TG, Clayman DA, Sanchez-Ramos L, et al. Brain in eclampsia: MR imaging with clinical correlation. Radiology 1991;180:475–78

   PubMedWeb of Science
5. ↵
   Lin JT, Wang WJ, Fuh JL, et al. Prolonged reversible vasospasm in cyclosporin A-induced encephalopathy. AJNR Am J Neuroradiol 2003;24:102–04

   Abstract/FREE Full Text
6. Ito T, Sakai T, Inagawa S, et al. MR angiography of cerebral vasospasm in preeclampsia. AJNR Am J Neuroradiol 1994;16:1344–47
7. ↵
   Shengar AR, Gupta RK, Dhanuka AK, et al. MR imaging, MR angiography and MR Spectroscopy of the brain in eclampsia. AJNR Am J Neuroradiol 1997;18:1485–90

   Abstract
8. ↵
   Schwartz RB, Jones KM, Kalina P, et al. Hypertensive encephalopathy: findings on CT, MR imaging and SPECT imaging in 14 cases. AJR Am J Roentgenol 1992;159:379–83

   CrossRefPubMedWeb of Science
9. ↵
   Rippe DJ, Edwards MK, Schrodt JF, et al. Reversible cerebral lesions associated with tiazofurin usage: MR demonstration. J Comput Assist Tomogr 1988;12:1078–81

   PubMed
10. Vaughn DJ, Jarvik JG, Hackney D, et al. High-dose cytarabine neurotoxicity: MR findings during acute phase. AJNR Am J Neuroradiol 1993;14:1014–16

    Abstract/FREE Full Text
11. ↵
    Ito Y, Arahata Y, Goto Y, et al. Cisplatin neurotoxicity presenting as reversible posterior leukoencephalopathy syndrome. AJNR Am J Neuroradiol 1998;19:415–17

    Abstract
12. ↵
    Hinchey J, Chaves C, Appignani B, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996;334:494–500

    CrossRefPubMedWeb of Science
13. Provenzale JM, Petrella JR, Cruz LC, et al. Quantitative assessment of diffusion abnormalities in posterior reversible encephalopathy syndrome. AJNR Am J Neuroradiol 2001;22:1455–61

    Abstract/FREE Full Text
14. Mukherjee P, McKinstry RC. Reversible posterior leukoencephalopathy syndrome: evaluation with diffusion-tensor MR imaging. Radiology 2001;219:756–65

    CrossRefPubMedWeb of Science
15. ↵
    Covarrubias DJ, Leutmer PH, Campeau NG. Posterior reversible encephalopathy syndrome: prognostic utility of quantitative diffusion-weighted MR images. AJNR Am J Neuroradiol 2002;23:1038–48

    Abstract/FREE Full Text
16. ↵
    Vincent JL, Moreno R, Takala J, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. Intensive Care Med 1996;22:707–10

    CrossRefPubMedWeb of Science
17. ↵
    Munford RS. Sepsis, severe sepsis, and septic shock. In: Mandell GL, Bennett JE, Dolin R eds. Principles and Practice of Infectious Disease. Philadelphia: Elsevier;2005 :906–26
18. ↵
    Schwartz RB, Feske SK, Polack JF, et al. Preeclampsia-eclampsia: clinical and neuroradiographic correlates and insights into the pathogenesis of hypertensive encephalopathy. Radiology 2000;217:371–76

    CrossRefPubMedWeb of Science
19. ↵
    Sibai BM. Eclampsia: maternal-perinatal outcome in 254 consecutive cases. Am J Obstet Gynecol 1990;163:1049–55

    CrossRefPubMedWeb of Science
20. ↵
    Gijtenbeek JMM, van den Bent MJ, Vecht CJ. Cyclosporine neurotoxicity: a review. J Neurol 1999;246:339–46

    CrossRefPubMedWeb of Science
21. ↵
    Bartynski WS, Zeigler ZR, Shadduck RK, et al. Pretransplantation conditioning influence on the incidence of cyclosporine and FK-506 neurotoxicity in allogeneic bone marrow transplantation. AJNR Am J Neuroradiol 2004;25:261–69

    Abstract/FREE Full Text
22. ↵
    Bartynski WS, Zeigler RZ, Shadduck RK, et al. Variable incidence of cyclosporine and FK-506 neurotoxicity in hematopoietic malignancies and marrow conditions after allogeneic bone marrow transplantation. Neurocritical Care 2005;3:33–45

    PubMed
23. ↵
    Scherrer U, Vissing SF, Morgan BJ, et al. Cyclosporine-induced sympathetic activation and hypertension after heart transplantation. N Engl J Med 1990;323:693–99

    CrossRefPubMedWeb of Science
24. ↵
    Mark AL. Cyclosporine, sympathetic activity, and hypertension. N Engl J Med 1990;323:748–50

    PubMedWeb of Science
25. ↵
    Brun-Buisson C, Doyon F, Carlet J, et al. Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. JAMA 1995;274:968–74

    CrossRefPubMedWeb of Science
26. ↵
    Sands KE, Bates DW, Lanken PN, et al. Epidemiology of sepsis syndrome in 8 academic medical centers. JAMA 1997;278:234–40

    CrossRefPubMedWeb of Science
27. ↵
    Rangel-Frausto MS, Pittet D, Costigan M, et al. The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 1995;273:117–23

    CrossRefPubMedWeb of Science
28. ↵
    Cohen J. The immunopathogenesis of sepsis. Nature 2002;420:885–91

    CrossRefPubMedWeb of Science
29. ↵
    Mutunga M, Fulton B, Bullock R, et al. Circulating endothelial cells in patients with septic shock. Am J Respir Crit Care Med 2001;163:195–200

    CrossRefPubMedWeb of Science
30. ↵
    Aird WC. The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood 2003;101:3765–77

    Abstract/FREE Full Text
31. ↵
    Parent C, Eichacker PQ. Neutrophil and endothelial cell interactions in sepsis. The role of adhesion molecules. Infect Dis Clin North Am 1999;13:427–47

    CrossRefPubMedWeb of Science
32. ↵
    Bannerman DD, Goldblum SE. Mechanisms of bacterial lipopolysaccharide-induced endothelial apoptosis. Am J Physiol Lung Cell Mol Physiol 2003;284:L899–914

    Abstract/FREE Full Text
33. ↵
    Symeonides S, Balk RA. Nitric oxide in the pathogenesis of sepsis. Infect Dis Clin North Am 1999;13:449–63

    CrossRefPubMedWeb of Science
34. ↵
    McCuskey RS, Urbaschek R, Urbaschek B. The microcirculation during endotoxemia. Cardiovasc Res 1996;752–63
35. ↵
    Wanecek M, Weitzberg E, Rudehill A, et al. The endothelin system in septic and endotoxin shock. Eur J Pharmacol 2000;407:1–15

    CrossRefPubMedWeb of Science
36. Weitzberg E, Lundberg JM, Rudehill A. Elevated plasma levels of endothelin in patients with sepsis syndrome. Circ Shock 1991;33:222–27

    PubMedWeb of Science
37. ↵
    Pittet JF, Morel DR, Hemsen A, et al. Elevated plasma endothelin-1 concentrations are associated with the severity of illness in patients with sepsis. Ann Surg 1991;213:261–64

    PubMedWeb of Science
38. ↵
    Marsden PA, Brenner BM. Transcriptional regulation of the endothelin-1 gene by TNF-α. Am J Physiol 1992;262:854–61
39. Mantovani A, Bussolino F, Dejanna E. Cytokine regulation of endothelial cell function. FASEB J 1992;6:2591–99

    Abstract
40. ↵
    Maemura K, Kurihara H, Morita T, et al. Production of endothelin-1 in vascular endothelial cells is regulated by factors associated with vascular injury. Gerontology 1992;38(Suppl 1):29–35
41. ↵
    Sugiura M, Inagami T, Kon V. Endotoxin stimulates endothelin-release in vivo and in vitro as determined by radioimmunoassay. Biochem Biophys Res Commun 1989;161:1220–27

    CrossRefPubMedWeb of Science
42. ↵
    Battistini B, Forget MA, Laight D. Potential roles for endothelins in inflammatory response syndrome with a particular relationship to cytokines. Shock 1996;5:167–83

    PubMedWeb of Science
43. Varon J, Marik PE. Multiple organ dysfunction syndrome. In: Irwin RS and Rippe JM, eds. Intensive Care Medicine. Philadelphia: Lippincott Williams & Wilkins;2003 :1834–38
44. ↵
    Rivers EP, Otero RM, Nguyen HB. Approach to the patient in shock. In: Tintinalli JE, Kelen GD, Stapczynski JS, eds. Emergency Medicine: A Comprehensive Study Guide. New York: McGraw Hill;2004 :219–25
45. ↵
    McGuire TR, Bociek GR, Pavletic SZ, et al. Organ dysfunction following stem cell transplantation: relationship to plasma cytokine concentrations. Bone Marrow Transplant 2001;28:889–93

    CrossRefPubMed
46. Gordon B, Lyden E, Lynch J, et al. Central nervous system dysfunction as the first manifestation of multiple organ dysfunction syndrome in stem cell transplant patients. Bone Marrow Transplant 2000;25:79–83

    CrossRefPubMed
47. ↵
    Haire W. The multiple organ dysfunction syndrome in cancer patients undergoing hematopoietic stem cell transplantation. Semin Thromb Hemost 1999;25:223–37

    PubMed
48. ↵
    Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999;6:448–54
49. ↵
    Eykyn SJ, Gransden WR, Phillips I. The causative organisms of septicaemia and their epidemiology. J Antimicrob Chemother 1990;25:41–58

    Abstract/FREE Full Text
50. Wisplinghoff H, Seifert H, Wenzel RP, et al. Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States. Clin Infect Dis 2003;36:1103–10

    Abstract/FREE Full Text
51. ↵
    Spanu T, Sanguinetti M, D’Inzeo T, et al. Identification of methicillin-resistant isolates of staphylococcus aureus and coagulase-negative staphylococci responsible for bloodstream infections with the Phoenix system. Diagn Microbiol Infect Dis 2004;48:221–27

    CrossRefPubMedWeb of Science
52. ↵
    Kotb M. Bacterial pyrogenic exotoxins as superantigens. Clin Microbiol Rev 1995;411–426
53. Sriskandan S, Cohen J. Gram-positive sepsis. Mechanisms and differences from gram-negative sepsis. Infect Dis Clin North Am 1999;13:397–412

    CrossRefPubMedWeb of Science
54. Unnikrishnan M, Altmann DM, Proft T, et al. The bacterial superantigen streptococcal mitogenic exotoxin Z is the major immunoactive agent of streptococcus pyogenes. J Immunol 2002;169:2561–69

    Abstract/FREE Full Text
55. Bannan J, Visvanathan K, Zabriskie. Structure and function of streptococcal and staphylococcal superantigens in septic shock. Infect Dis Clin North Am 1999;13:387–463

    CrossRefPubMedWeb of Science
56. ↵
    Cohen SS. Gram-positive sepsis. Mechanisms and differences from gram-negative sepsis. Infect Dis Clin North Am 1999;13:397–412

    CrossRefPubMedWeb of Science
57. ↵
    Ferrara JLM. Pathogenesis of acute graft-versus-host disease: cytokines and cellular effectors. J Hematother Stem Cell Res 2000;9:299–306

    CrossRefPubMed
58. ↵
    Martin GS, Mannino DM, Eaton S, et al. The epidemiology of sepsis in the United States from 1979–2000. N Engl J Med 2003;348:1546–54

    CrossRefPubMedWeb of Science
59. ↵
    Hypertensive disorders in pregnancy. In: Cunningham FG, Gant NF, Leveno KJ, et al, eds. Williams Obstetrics, 21st ed. New York: McGraw-Hill;2001 :567–618
60. Dekker GA, Sibai BM. Etiology and pathogenesis of pre-eclampsia: current concepts. Am J Obstet Gynecol 1998;179:1359–75

    CrossRefPubMedWeb of Science
61. ↵
    The placenta and fetal membranes. In: Cunningham FG, Gant NF, Leveno KJ, et al, eds. Williams Obstetrics, 21st ed. New York: McGraw-Hill;2001 :85–108
62. ↵
    Bradley JR, Lockwood CM, Thiru S. Endothelial cell activation in patients with systemic vasculitis. Q J Med 1994;87:741–45

    Abstract/FREE Full Text
63. Pall AA, Savage COS. Mechanisms of endothelial cell injury in vasculitis. Springer-Verlag Semin Immunopathol 1994;16:23–27
64. Smith EA. Systemic sclerosis: etiology and pathogenesis. In: Hochberg MC, Silman AJ, Smolen JS, et al, eds. Rheumatology, 3rd ed. Edinburgh: Mosby;2003 :1481–92
65. Crow MK. Cellular immunity. Systemic lupus erythmatosis. In: Hochberg MC, Silman AJ, Smolen JS, et al, eds. Rheumatology, 3rd ed. Edinburgh: Mosby;2003 :1347–58
66. ↵
    Stone JH, Hoffman GS. Wegener’s granulomatosis and lymphoid granulomatosis. In: Hochberg MC, Silman AJ, Smolen JS, et al, eds. Rheumatology, 3rd ed. Edinburgh: Mosby;2003 :1624–34
67. ↵
    Burt RK, Walsh T. Infection prophylaxis in bone marrow transplant recipients—myths, legends, and microbes. In: On Call in Bone Marrow Transplantation. Burt RK, Deeg HJ, Lothian ST, et al, eds. Georgetown, Tex: Landes Bioscience;1996 :439–451
68. Burns WH. Virus infections complicating bone marrow translation. In: On Call in Bone Marrow Transplantation. Burt RK, Deeg HJ, Lothian ST, et al, eds. Georgetown, Tex: Landes Bioscience;1996 :439–451
69. ↵
    Stosor V. Infection in transplant recipients. In: On Call in Bone Marrow Transplantation. Burt RK, Deeg HJ, Lothian ST, et al, eds. Georgetown, Tex: Landes Bioscience;1996 :399–425
70. ↵
    Ramanathan V, Helderman JH. Cyclosporine formulations. In: Sayegh M, Remuzzi G, eds. Current and Future Immunosuppressive Therapies following Transplantation. Netherlands: Kluwer Academic;2001 :111–21
71. Shapiro R. Tacrolimus. In: Sayegh M, Remuzzi G, eds. Current and Future Immunosuppressive Therapies following Transplantation. Netherlands: Kluwer Academic;2001 :123–42
72. ↵
    Holler E, Kolb HJ, Hiller E, et al. Microangiopathy in patients on cyclosporine prophylaxis who developed acute graft-versus-host disease after HLA-identical bone marrow transplantation. Blood 1989;73:2018–24

    Abstract/FREE Full Text
73. ↵
    Hill GR, Crawford JM, Cooke KR, et al. Total body irradiation and acute graft-versus-host disease: the role of gastrointestinal damage and inflammatory cytokines. Blood 1997;90:3204–13

    Abstract/FREE Full Text
74. Antin JH, Ferrara JLM. Cytokine dysregulation and acute graft-versus-host disease. Blood 1992;80:2964–68

    Abstract/FREE Full Text
75. Holler E, Kolb HJ, Moller A, et al. Increased serum levels of tumor necrosis factor α precede major complications of bone marrow transplantation. Blood 1990;75:1011–16

    Abstract/FREE Full Text
76. ↵
    Schots R, Kaufman L, Van Riet I, et al. Proinflammatory cytokines and their role in the development of major transplant-related complications in the early phase after allogeneic bone marrow transplantation. Leukemia 2003;12:1150–56
77. ↵
    Halloran PF, Batiuk TD, Goes N, et al. Immunologic concepts. In: Stuart FP, Abecassis MM, Kaufman DB eds. Organ Transplantation. Georgetown, Tex: Landes Bioscience;2003 :1–44
78. ↵
    Cerilli J, Brasile L, Galouzis T, et al. The vascular endothelial cell antigen system. Transplantation 1985;39:286–89

    PubMed